{"qas": [{"question": "For what type of goods are IP's ethical problems most pertinent?", "id": "572657b6dd62a815002e8228", "answers": [{"text": "socially valuable", "answer_start": 102}], "is_impossible": false}, {"question": "What is an example of socially valuable goods?", "id": "572657b6dd62a815002e8229", "answers": [{"text": "life-saving medicines", "answer_start": 131}], "is_impossible": false}, {"question": "What cost does IP rights allow companies to charge higher than?", "id": "572657b6dd62a815002e822a", "answers": [{"text": "the marginal cost of production", "answer_start": 255}], "is_impossible": false}, {"question": "Who might a higher price exclude from the market?", "id": "572657b6dd62a815002e822b", "answers": [{"text": "anyone who cannot afford the cost of the product", "answer_start": 383}], "is_impossible": false}, {"plausible_answers": [{"text": "higher than the marginal cost of production", "answer_start": 243}], "question": "What do IP rights keep companies from charging?", "id": "5a15bd36a54d4200185294c7", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "products that are socially valuable", "answer_start": 561}], "question": "What does an IRP driven regime encourage production of four poor populations?", "id": "5a15bd36a54d4200185294c8", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "socially valuable goods", "answer_start": 102}], "question": "What type of goods are exempt from the ethical problems brought on by IP rights?", "id": "5a15bd36a54d4200185294c9", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "the costs of research and development", "answer_start": 306}], "question": "What do IP rights keep companies from recouping?", "id": "5a15bd36a54d4200185294ca", "answers": [], "is_impossible": true}], "context": "Further along these lines, The ethical problems brought up by IP rights are most pertinent when it is <a0_0><b6_0>socially valuable<a0_0/> goods<b6_0/> like <a1_0>life-saving medicines<a1_0/> are given IP protection. While the application of IP rights can allow companies to charge <b4_0>higher than <a2_0>the marginal cost of production<b4_0/><a2_0/> in order to recoup <b7_0>the costs of research and development<b7_0/>, the price may exclude from the market <a3_0>anyone who cannot afford the cost of the product<a3_0/>, in this case a life-saving drug. \"An IPR driven regime is therefore not a regime that is conductive to the investment of R&D of <b5_0>products that are socially valuable<b5_0/> to predominately poor populations\".:1108\u20139"}